GNRH1 and ovarian hyperstimulation syndrome: This coincides with other authors’ recommendations for GnRH agonist trigger use in freeze-all cycles and oocyte donation programs to minimize OHSS risk without negatively impacting pregnancy outcomes (11, 26).